Now, two new late-phase clinical trials, sponsored by Eli Lilly and Company, suggest that transitioning from high dose injectable weight loss medications to either a daily pill or a lower maintenance dose can help people living with obesity to keep off most of the weight they have already lost The results of the ATTAIN-MAINTAIN and SURMOUNT-MAINTAIN trials were presented at the European Congress on Obesity and published in Previous research suggests that 1 year after stopping weight loss medication, people may regain, on average, 60% of their lost weight
Some patients describe previously enjoyed desserts, chocolate, or sugary beverages as less palatable or even unpleasant
However, just because a side effect is common doesnt mean its well understood
It helps regulate blood sugar, slows stomach emptying, and makes you feel full for longer
Potential for Improved Tolerability: The avoidance of -arrestin recruitment may also help improve the tolerability of the drug, since a common side effect associated with GLP-1 receptor agonists is gastrointestinal distress
The criteria are specific and narrower than they sound: a BMI of 35 or higher qualifies on its own
-1775582746855.png&w=3840&q=75)
